MICROCOMPUTER CONTROLLED SELF TONOMETER FOR HOME MONITOR

描述（研究者摘要）：在治疗青光眼时，临床医生 尝试降低患者的眼内压（IOP）。 IOP不是 然而，在访问期间进行的一次测量是恒定的， 眼科医生可能不可靠。 IOP的理想测量 由于缺少仪器，在病人家中的检查受到了阻碍。 一 自我眼压计，最近开发和实施的临床研究， 在《国家环境倡议》中确定的优先领域取得的进展中， 国家计划。 这项建议的目标是使自我眼压计 通过将其转化为商业产品， 产品 第二阶段旨在完成一项 微型计算机;编写程序来分析读数，并提供即时 反馈给患者;允许电池运行;升级传感器 进入可制造组件;开发一次性探头;编写 用于办公室计算机的程序，用于下载数据并显示昼夜IOP 曲线. 自我眼压计将在10个诊所进行评估 独立的青光眼专家;其读数将与 Goldmann眼压计;及其在监测 青光眼患者在他们的家中和工作场所将被评估。 III期 将致力于制造仪器，并获得FDA 批准其商业用途。

DESCRIPTION (Investigator's Abstract): In treating glaucoma, clinicians attempt to lower patient's intraocular pressure (IOP). The IOP is not constant however, and a single measurement taken during a visit to the ophthalmologist may be unreliable. The desireable measurement of the IOP at the patient's home has been hampered by the lack of an instrument. A self-tonometer, recently developed and implemented in clinical research, has been cited among the progresses in the priority areas set in the NEI National Plan. The goal of this proposal is to make the self-tonometer available to the ophthalmic community by converting it into a commercial product. Phase II is designed to complete the implementation of a microcomputer; write programs to analyze the readings and provide immediate feedback to the patient; allow for battery operation; upgrade the sensor head into a manufacturable component; develop a disposable probe; write a program for office computers to download the data and present diurnal IOP curves. The self-tonometer will be evaluated in the clinics of ten independent glaucoma experts; its readings will be correlated with those of the Goldmann tonometer; and its application to monitoring the IOP of glaucoma patients at their home and work place will be assessed. Phase III will be dedicated to manufacturing the instrument and obtaining FDA approval for its commercial use.